{"id":"W3131883755","doi":"10.1158/1538-7445.sabcs20-ps9-55","title":"Abstract PS9-55: Subcutaneous fixed-dose combination of pertuzumab and trastuzumab for the treatment of metastatic breast cancer in Canada - a budget impact analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Roche (Canada)","funders":"","keywords":"Medicine; Pertuzumab; Metastatic breast cancer; Trastuzumab; Breast cancer; Taxane; Pharmacokinetics; Cancer; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004294053,0.001303906,0.00139494,0.002788744,0.0007622612,0.002268218,0.001783945,0.0008537471,0.00482194],"category_scores_gemma":[0.007667518,0.001011612,0.003069008,0.003970291,0.0006784836,0.0007559046,0.0009368775,0.001578342,0.0002775299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08667492,"about_ca_system_score_gemma":0.0565603,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9461162,"about_ca_topic_score_gemma":0.9005401,"domain_scores_codex":[0.997637,0.0008231627,0.00008807372,0.0001742628,0.0005908196,0.0006865658],"domain_scores_gemma":[0.9959744,0.001631092,0.0005745774,0.0001052256,0.001256603,0.0004581153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002563717,0.0003766943,0.02913938,0.0006645198,0.001495786,0.0003037781,0.00004966329,0.9424313,0.0003618234,0.003604223,0.00451187,0.01449728],"study_design_scores_gemma":[0.002938701,0.001535219,0.07635739,0.0005961448,0.003152731,0.0002047125,0.000455284,0.900131,0.0008064701,0.001942866,0.01173103,0.0001484044],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.885245,0.006738217,0.01009355,0.003542982,0.00009725618,0.004301402,0.05223011,0.000198071,0.03755336],"genre_scores_gemma":[0.983518,0.001788311,0.003372404,0.000284197,0.00001903272,0.0004620985,0.007129789,0.00002124412,0.003405002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08667492,"threshold_uncertainty_score":0.6288735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05739469193463603,"score_gpt":0.345171524895353,"score_spread":0.287776832960717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}